Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
group | 0.500 | None | 1.000 | 38 | 0 | 1995 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.500 | None | 0.969 | 32 | 1 | 2005 | 2019 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
group | 0.430 | None | 1.000 | 3 | 0 | 2014 | 2018 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
group | 0.410 | None | 1.000 | 1 | 1 | 2012 | 2013 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2006 | 2014 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.400 | None | 1.000 | 19 | 0 | 1993 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.400 | None | 1.000 | 14 | 0 | 2010 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2010 | 2019 | ||||||||
|
heat shock protein family A (Hsp70) member 5 | 0.434 | 0.885 | 0.77 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.200 | None | 1.000 | 14 | 0 | 2010 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.140 | None | 1.000 | 4 | 2 | 2001 | 2018 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.140 | None | 0.750 | 4 | 0 | 1997 | 2006 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.130 | None | 1.000 | 3 | 0 | 2002 | 2006 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
group | 0.100 | None | 0.977 | 43 | 0 | 2002 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 1.000 | 43 | 0 | 1991 | 2019 | ||||||||
|
tripartite motif containing 13 | 0.462 | 0.846 | 0.64 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | |||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
CXADR Ig-like cell adhesion molecule | 0.454 | 0.885 | 0.37 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.100 | None | 0.951 | 41 | 3 | 1993 | 2019 |